Trial Profile
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR): A Phase II Basket Trial
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2024
Price :
$35
*
At a glance
- Drugs Axitinib (Primary) ; Bosutinib (Primary) ; Cobimetinib (Primary) ; Crizotinib (Primary) ; Dasatinib (Primary) ; Erlotinib (Primary) ; Ipilimumab (Primary) ; Nivolumab (Primary) ; Olaparib (Primary) ; Palbociclib (Primary) ; Pertuzumab (Primary) ; Sunitinib (Primary) ; Temsirolimus (Primary) ; Trastuzumab (Primary) ; Tucatinib (Primary) ; Vemurafenib (Primary) ; Vismodegib (Primary)
- Indications Multiple myeloma; Non-Hodgkin's lymphoma; Solid tumours
- Focus Therapeutic Use
- Acronyms CAPTUR
- 09 Jan 2023 Planned End Date changed from 30 Sep 2023 to 31 Jan 2027.
- 09 Jan 2023 Planned primary completion date changed from 30 Jun 2023 to 31 Jan 2026.
- 08 Nov 2022 Planned primary completion date changed from 30 Sep 2022 to 30 Jun 2023.